Literature DB >> 26959110

Clinical management of pulmonary sarcoidosis.

Ying Zhou1,2, Elyse E Lower1, Huiping Li2, Robert P Baughman1.   

Abstract

Sarcoidosis is a multisystem disease for which diagnosis relies on the integration of clinical, radiologic, laboratory, and pathologic information. Assessment of clinical features is an important part of the disease evaluation. Computer Tomography provides information not available on routine chest roentgenogram which can assist diagnosing and establishing extent of disease. Monitoring for pulmonary and extra-pulmonary disease facilitates disease management. Patients with quality of life affecting symptoms or threatened end organ damage require systemic treatment which can be recommended in a stepwise fashion. Here, we provide guidance for the initial assessment, disease monitoring, and treatment recommendations for pulmonary and extra pulmonary disease.

Entities:  

Keywords:  CT scan; Infliximab; Methotrexate; PET scan; Prednisone; Sarcoidosis; pulmonary

Mesh:

Year:  2016        PMID: 26959110     DOI: 10.1586/17476348.2016.1164602

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  8 in total

1.  Serum soluble interleukin-2 receptor level is a predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis.

Authors:  Jun Miyata; Takunori Ogawa; Yoichi Tagami; Takashi Sato; Mikie Nagayama; Toshiyuki Hirano; Naofumi Kameyama; Koichi Fukunaga; Akihiko Kawana; Takashi Inoue
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-15       Impact factor: 0.670

2.  Chest high-resolution computed tomography can make higher accurate stages for thoracic sarcoidosis than X-ray.

Authors:  Yuan Zhang; Shan-Shan Du; Meng-Meng Zhao; Qiu-Hong Li; Ying Zhou; Jia-Cui Song; Tao Chen; Jing-Yun Shi; Bing Jie; Wei Li; Li Shen; Fen Zhang; Yi-Liang Su; Yang Hu; Elyse E Lower; Robert P Baughman; Huiping Li
Journal:  BMC Pulm Med       Date:  2022-04-16       Impact factor: 3.317

Review 3.  Contemporary optimized practice in the management of pulmonary sarcoidosis.

Authors:  Shambhu Aryal; Steven D Nathan
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

4.  Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis.

Authors:  Ada E M Bloem; Rémy L M Mostard; Naomi Stoot; Jan H Vercoulen; Jeannette B Peters; Daisy J A Janssen; Jan W H Custers; Martijn A Spruit
Journal:  J Clin Med       Date:  2020-04-20       Impact factor: 4.241

5.  Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis.

Authors:  Ada E M Bloem; Rémy L M Mostard; Naomi Stoot; Jan H Vercoulen; Jeannette B Peters; Martijn A Spruit
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

6.  Application of neck ultrasound in the diagnosis of sarcoidosis.

Authors:  Mengjun Shen; Ying Zhou; Weiqing Gu; Chengsheng Yin; Yin Wang; Yuan Zhang
Journal:  BMC Pulm Med       Date:  2021-12-15       Impact factor: 3.317

7.  Value of 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the differential diagnosis of sarcoidosis and lung cancer with lymph node metastasis: a retrospective study.

Authors:  Xianqiu Chen; Xin Xu; Serafeim Chrysikos; Mengmeng Zhao; Ying Zhou
Journal:  Transl Lung Cancer Res       Date:  2022-09

8.  Vaccination status of patients using anti-TNF therapy and the physicians' behavior shaping the phenomenon: Mixed-methods approach.

Authors:  Hussain Abdulrahman Al-Omar; Hadeel Magdy Sherif; Ahmed Yaccob Mayet
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.